Clearside Biomedical, Inc. CLSD
Set alert
0.41 USD 0.00 0.00%
At close · Oct 28
Day range unavailable
52-week range unavailable
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- —
- Prev close
- 0.41
- Mkt cap
- 2.15M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -1.76
- Beta
- 2.33
- Short ratio
- 1.21
- Inst. own
- 23.17%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.07
- 200-d avg
- 1.22
- 1y target
- 6.00
Analyst view
Consensus: none
Price target (mean) 6.00 +1363.4% upside
Now 0.41
- Target (low)
- 5.00
- Target (mean)
- 6.00
- Target (high)
- 8.00
Ratings (0m) 7 7 buy · 0 hold · 0 sell
- Strong buy3
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 7
- 3 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.098 | -0.13 – -0.04 | -0.08 | -22.5% | 294.43K | -95.4% | 5 |
| Next quarter | -0.085 | -0.13 – -0.04 | -0.17 | +50.0% | 100.00K | -56.5% | 2 |
| Current year | -0.47 | -0.50 – -0.42 | -0.53 | +11.3% | 1.68M | -79.6% | 5 |
| Next year | -0.438 | -0.53 – -0.36 | -0.47 | +6.8% | 2.98M | +78.0% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 15, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Nov 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 13, 2024 | Needham | Reiterated | Buy | Buy |
| Oct 14, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Oct 10, 2024 | Needham | Maintained | Buy | Buy |
| Aug 27, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 21, 2024 | Chardan Capital | Initiated | — | Buy |
| Aug 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 13, 2024 | Needham | Reiterated | Buy | Buy |
| Jul 30, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 25, 2024 | Needham | Reiterated | Buy | Buy |
| Jun 25, 2024 | Oppenheimer | Initiated | — | Outperform |
| May 13, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 13, 2024 | Needham | Reiterated | Buy | Buy |
| Apr 11, 2024 | Needham | Reiterated | Buy | Buy |
| Mar 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 13, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Mar 13, 2024 | Wedbush | Maintained | Outperform | Outperform |
| Mar 13, 2024 | Needham | Reiterated | Buy | Buy |
| Nov 14, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 6, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 15, 2023 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Aug 15, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 15, 2023 | Needham | Reiterated | Buy | Buy |
| Jul 19, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 12, 2023 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Jul 10, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 14, 2023 | JonesTrading | Initiated | — | Buy |
| Jun 1, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 12, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |